Interplay between three RND efflux pumps in doxycycline-selected strains of Burkholderia thailandensis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Biot, Fabrice Vincent ^a,b   Lopez, Mélanie Monique ^a   Poyot, Thomas ^a   Neulat Ripoll, Fabienne ^a,b   Lignon, Sabrina ^c   Caclard, Arnaud ^a,b   Thibault, François Michel ^a,b   Peinnequin, Andre ^a   Pages̀, Jean Marie ^b   Valade, Eric ^a,b,d  

^a INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^b Aix Marseille University   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d Ecole du Val de Grace   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BURKHOLDERIA; DIPEPTIDES; DOXYCYCLINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOTYPE; PROTEOMICS;

EID: 84893563135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084068     Document Type: Article

References (42)

1. Nikaido H (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78: 119-146.
2. Schweizer HP (2012) Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiol 7: 1389-1399.
3. Simpson AJ, White NJ, Wuthiekanun V (1999) Aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 43: 2332. (Pubitemid 29421229)
4. Chan YY, Tan TM, Ong YM, Chua KL (2004) BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob Agents Chemother 48: 1128-1135. (Pubitemid 38405465)
5. Chan YY, Chua KL (2005) The Burkholderia pseudomallei BpeAB-OprB efflux pump: expression and impact on quorum sensing and virulence. J Bacteriol 187: 4707-4719. (Pubitemid 40962188)
6. Kumar A, Chua KL, Schweizer HP (2006) Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob Agents Chemother 50: 3460-3463. (Pubitemid 44527526)
7. Trunck LA, Propst KL, Wuthiekanun V, Tuanyok A, Beckstrom-Sternberg SM, et al. (2009) Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis 3: e519.
8. Mima T, Schweizer HP (2010) The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob Agents Chemother 54: 3113-3120.
9. Podnecky NL, Wuthiekanun V, Peacock SJ, Schweizer HP (2013) The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates. Antimicrob Agents Chemother 57: 4381-4386.
10. Nikaido H, Takatsuka Y (2009) Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta 1794: 769-781.
11. Brett PJ, DeShazer D, Woods DE (1998) Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei -like species. Int J Syst Bacteriol 48 Pt 1: 317-320. (Pubitemid 28144666)
12. Glass MB, Gee JE, Steigerwalt AG, Cavuoti D, Barton T, et al. (2006) Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol 44: 4601-4604. (Pubitemid 44937108)
13. Carr G, Seyedsayamdost MR, Chandler JR, Greenberg EP, Clardy J (2011) Sources of diversity in bactobolin biosynthesis by Burkholderia thailandensis E264. Org Lett 13: 3048-3051.
14. Biot FV, Valade E, Garnotel E, Chevalier J, Villard C, et al. (2011) Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence. PLoS One 6: e16892.
15. Griffin MO, Fricovsky E, Ceballos G, Villarreal F (2010) Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299: C539-548.
16. Gelhaus HC, Anderson MS, Fisher DA, Flavin MT, Xu ZQ, et al. (2013) Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis. Sci Rep 3: 1146.
17. Sarkar-Tyson M, Atkins HS (2011) Antimicrobials for bacterial bioterrorism agents. Future Microbiol 6: 667-676.
18. Udani RA, Levy SB (2006) MarA-like regulator of multidrug resistance in Yersinia pestis. Antimicrob Agents Chemother 50: 2971-2975. (Pubitemid 44396400)
19. Mima T, Schweizer HP, Xu ZQ (2011) In vitro activity of cethromycin against Burkholderia pseudomallei and investigation of mechanism of resistance. J Antimicrob Chemother 66: 73-78.
20. Viktorov DV, Zakharova IB, Podshivalova MV, Kalinkina EV, Merinova OA, et al. (2008) High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species. Trans R Soc Trop Med Hyg 102 Suppl 1: S103-110.
21. Thongdee M, Gallagher LA, Schell M, Dharakul T, Songsivilai S, et al. (2008) Targeted mutagenesis of Burkholderia thailandensis and Burkholderia pseudomallei through natural transformation of PCR fragments. Appl Environ Microbiol 74: 2985-2989. (Pubitemid 351747000)
22. Chevalier J, Bredin J, Mahamoud A, Mallea M, Barbe J, et al. (2004) Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains. Antimicrob Agents Chemother 48: 1043-1046. (Pubitemid 38280366)
23. Ghisalberti D, Masi M, Pages JM, Chevalier J (2005) Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 328: 1113-1118. (Pubitemid 40238749)
24. Bornet C, Chollet R, Mallea M, Chevalier J, Davin-Regli A, et al. (2003) Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 301: 985-990. (Pubitemid 36279211)
25. Blouzard JC, Coutinho PM, Fierobe HP, Henrissat B, Lignon S, et al. (2010) Modulation of cellulosome composition in Clostridium cellulolyticum: adaptation to the polysaccharide environment revealed by proteomic and carbohydrate-active enzyme analyses. Proteomics 10: 541-554.
26. Pugniere P, Banzet S, Chaillou T, Mouret C, Peinnequin A (2011) Pitfalls of reverse transcription quantitative polymerase chain reaction standardization: Volume-related inhibitors of reverse transcription. Anal Biochem 415: 151-157.
27. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, et al. (2004) Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 5: 3.
28. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
29. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
30. Willems E, Leyns L, Vandesompele J (2008) Standardization of real-time PCR gene expression data from independent biological replicates. Anal Biochem 379: 127-129.
31. Bolla JM, Alibert-Franco S, Handzlik J, Chevalier J, Mahamoud A, et al. (2011) Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria. FEBS Lett 585: 1682-1690.
32. Cortez-Cordova J, Kumar A (2011) Activity of the efflux pump inhibitor phenylalanine-arginine beta-naphthylamide against the AdeFGH pump of Acinetobacter baumannii. Int J Antimicrob Agents 37: 420-424.
33. Pages JM, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, et al. (2009) Efflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS One 4: e4817.
34. Pannek S, Higgins PG, Steinke P, Jonas D, Akova M, et al. (2006) Multidrug efflux inhibition in Acinetobacter baumannii : comparison between 1-(1-naphthyl-methyl)-piperazine and phenyl-arginine-beta-naphthylamide. J Antimicrob Chemother 57: 970-974.
35. Rajendran R, Quinn RF, Murray C, McCulloch E, Williams C, et al. (2010) Efflux pumps may play a role in tigecycline resistance in Burkholderia species. Int J Antimicrob Agents 36: 151-154.
36. Yu Y, Kim HS, Chua HH, Lin CH, Sim SH, et al. (2006) Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC Microbiol 6: 46.
37. Li XZ, Nikaido H, Poole K (1995) Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa . Antimicrob Agents Chemother 39: 1948-1953.
38. Jeannot K, Sobel ML, El Garch F, Poole K, Plesiat P (2005) Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction. J Bacteriol 187: 5341-5346. (Pubitemid 41022953)
39. Kumar A, Mayo M, Trunck LA, Cheng AC, Currie BJ, et al. (2008) Expression of resistance-nodulation-cell-division efflux pumps in commonly used Burkholderia pseudomallei strains and clinical isolates from northern Australia. Trans R Soc Trop Med Hyg 102 Suppl 1: S145-151.
40. Dance DA, Wuthiekanun V, Chaowagul W, White NJ (1989) The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 24: 295-309. (Pubitemid 19238292)
41. Gotoh N, Tsujimoto H, Tsuda M, Okamoto K, Nomura A, et al. (1998) Characterization of the MexC-MexD-OprJ multidrug efflux system in DmexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 42: 1938-1943. (Pubitemid 28363073)
42. Lister IM, Raftery C, Mecsas J, Levy SB (2012) Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrob Agents Chemother 56: 1120-1123.